Skip to main content

Premaitha share placing raises £1.5m

Premaitha share placing raises £1.5m

Manchester-headquartered molecular diagnostics company Premaitha Health has raised £1.5m through a share placing with Harwood Capital.

 

Adam Reynolds, chairman of Premaitha Health, said: “We are delighted that a fund of Harwood’s quality has identified the opportunity in Premaitha. Their investment follows evidence of further traction with the IONA test in key markets and the recent announcement of our conditional acquisition of Taiwan-based Yourgene Bioscience, which brings expanded market access into Asia – the fastest growing market for non-invasive prenatal testing.”

See the article in full at InsiderMedia.com